Similar Articles
1021 Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma
1022 Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma
1023 Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinoma
1024 Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation
1025 Current status and perspectives of immune-based therapies for hepatocellular carcinoma
1026 Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
1027 Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
1028 Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?
1029 Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes
1030 Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA